Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkins Lymphoma

Explore clinical trials studying Non-Hodgkins Lymphoma. Study availability and eligibility vary by location and protocol.

36 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkins Lymphoma trial results

Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details
Completed

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

NCT00179673

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Alta Bates Cancer Center Berkeley, California, United States
  • Pacific Coast Hematology/Oncology Medical Group, Onc. Fountain Valley, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 15 locations
View Trial Details

Related conditions